It is all about securing the CAR-T cells for the trials at this stage. The next problem would be how to secure the cells should Azer-Cel become an approved treatment as multiples of the current production would be needed. If IMU is clever they will sell Azer-Cel and leave that problem to the buyer / partner who might have their own facility.
The cost reduction is significant while they ( hopefully ) still have access to their cells. But I guess LC will have that sorted.
A few times I wrote about some PH-decisions that made no sense at all at that time " I hope one day we can say - Ah, that's why! " Today is one of those days as it now makes sense that CHM has secured its own cells independent of IMU. A shared facility would have made sense for both in September '23 but both LC and CHM's JC told me that won't happen - now we know why. If all the other Hopper decisions will make sense in the LT then I owe him a big apology.
GLTA
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene and Kincell Bio Announce Strategic Partnership
Ann: Imugene and Kincell Bio Announce Strategic Partnership, page-92
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 3441484 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 574188 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 2626814 | 0.054 |
21 | 3124322 | 0.053 |
28 | 4941821 | 0.052 |
31 | 3703294 | 0.051 |
70 | 6394327 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 401800 | 3 |
0.056 | 100000 | 1 |
0.057 | 444535 | 7 |
0.058 | 400000 | 2 |
0.059 | 350000 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |